The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations

AA Ali, A Fouda, K Abdelkawy… - European Journal of …, 2021 - journals.lww.com
Background Nonalcoholic fatty liver disease (NAFLD) is a common liver problem, including
both nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In this study …

The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations

AA Ali, A Fouda, K Abdelkawy… - European Journal of …, 2022 - ingentaconnect.com
Background Nonalcoholic fatty liver disease (NAFLD) is a common liver problem, including
both nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In this study …

The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations.

AA Ali, A Fouda, ES Abdelaziz… - European Journal of …, 2021 - europepmc.org
Background Nonalcoholic fatty liver disease (NAFLD) is a common liver problem, including
both nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In this study …

The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations

AA Ali, A Fouda, K Abdelkawy… - European journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Nonalcoholic fatty liver disease (NAFLD) is a common liver problem, including
both nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In this study …